Diabetic neuropathy management
Global and regional diabetes prevalence estimates for and projections for and results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. Changes in features of diabetes care in Hungary in the period of years — Aims and methods of the database analysis of the National Health Insurance Fund. Az Országos Egészségbiztosítási Pénztár adatbázis-elemzésének célja és módszertana. Decreasing incidence of pharmacologically treated type 2 diabetes in Hungary from to a nationwide diabetic neuropathy management study.
Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature. Prevalence of neuropathy in diabetes mellitus. In: Kempler P, Várkonyi T.
Neuropathies in clinical practice.
Neuropathiák a klinikai gyakorlatban. Risk factors and comorbidities in diabetic neuropathy: an update Rev Diabet Stud.
The effect of cigarette smoking on diabetic peripheral neuropathy: a systematic review and meta-analysis. J Gen Intern Med. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes. Atherosclerosis ; — Painful diabetic neuropathy: epidemiology, natural history, early diabetic neuropathy management, and treatment options.
The role of glycaemic control and management of cardiovascular risk factors in the prevention and treatment of neuropathic complications are discussed. Diabetic neuropathy management further options of pathogenetic ally oriented treatment, recent knowledge on benfotiamine and alpha-lipoic acid is comprehensively reviewed. Alpha-lipoic acid is a powerful antioxidant and clinical trials have proven its efficacy in ameliorating neuropathic signs and symptoms. Benfotiamine acts via the activation of transketolase and thereby inhibits alternative pathways triggered by uncontrolled glucose influx in the cells comprising polyol, hexosamine, protein-kinase-C pathways and formation of advanced glycation end products.
Pain Med. Painful diabetic peripheral neuropathy — health care costs and complications from to Neurol Clin Pract. Risk factors of dialysis and mortality in type 1 and 2 diabetes. A nationwide study.
Széleskörű hazai felmérés. Can diabetic polyneuropathy and foot ulcers in patients with type 2 diabetes be accurately identified based on ICD hospital diagnoses and drug prescriptions?
Clin Epidemiol.
Annual health insurance treatment cost of diabetic polyneuropathy based on routinely collected financing data. Value Health ; 23 Suppl 1 : S Epidemiological disease burden of diabetic polyneuropathy based on routinely collected health insurance claims data. Value Health Reg Issues ; 7: 27— Utilization indicators of balneotherapy in Hungary.
У нас две рыжеволосые. Обе хорошенькие. Сердце Беккера подпрыгнуло. - Очень хорошенькие? - повторил он с нарочитым немецким акцентом.
Changes in diabetic neuropathy management health status of the population of Central and Eastern European countries between and Eur J Health Econ. Multicriteria decision analysis in the reimbursement of new medical technologies: real-world experiences from Hungary.
Value Health ; — Financial deficits in the health services of the UK and Hungary. Lancet ; — Health insurance pharmaceutical expenditures in Hungary. Further steps in the development of pharmacoeconomics, outcomes research, and health technology assessment in Central and Eastern Europe, Western Asia, and Africa. Value Health Reg Issues ; 2: — Price competition and reimbursement of biosimilar granulocyte-colony stimulating factor in Hungary.
Expert Rev Pharmacoecon Diabetic neuropathy management Res. Financing of health care services in Hungary. Global, regional, and national age-sex-specific mortality for causes of death in countries and territories, — a systematic analysis for the Global Burden of Disease Study World Health Organization, Geneva, Global, regional, and national incidence, prevalence, and years lived with disability for diseases and injuries for countries and territories, — a systematic analysis for the Global Burden of Disease Study Epidemiology of type 2 diabetes — Global Burden of Disease and forecasted trends.
Managing diabetic neuropathy
J Epidemiol Glob Health ; — Diabetic foot syndrome. Peripheral arterial disease and diabetes related lower limb amputations.
Presentation of the epidemiological data and the analysis of potentialities in preventive strategy. Epidemiológiai adatok bemutatása és a megelőző stratégia lehetőségeinek elemzése.
На террасе тоже было полно панков, но Беккеру она показалась чем-то вроде Шангри-Ла: ночное летнее небо над головой, тихие волны долетающей из зала музыки. Не обращая внимания на устремленные на него любопытные взгляды десятков пар глаз, Беккер шагнул в толпу. Он ослабил узел галстука и рухнул на стул у ближайшего свободного столика. Казалось, что с той минуты, когда рано утром ему позвонил Стратмор, прошла целая вечность.
Ischemic origin of diabetic foot disease. Epidemiology, difficulties of diagnosis, options for prevention and revascularization. Epidemiológia, a diabetic neuropathy management nehézségei, prevenciós és revascularisatiós lehetőségek.
The diabetic foot syndrome: pathomechanism, clinical picture, current treatment and prevention. Diabetic neuropathies: components of etiology. J Peripher Nerv Syst.
Advances in the management of diabetic neuropathy
Diabet Med. Assessing the effect of the public health product tax in Hungary between — Value Health ; 21 Suppl 2 : S Healthcare professional guideline — Treatment of adult diabetic foot syndrome patients pathology, diagnostics, therapy, prevention. Health insurance aspects of physiotherapeutic care of neurology disorders in outpatient care.
The effect of performance-volume limit on the DRG based acute care hospital financing in Hungary.
- Péter Kempler - Google Tudós
- Anna Körei - Google Tudós
- Advances in the management of diabetic neuropathy - SZTE Publicatio Repozitórium
- Что вам .
- Új kezelésében az 1. típusú diabétesz németországban
Health Policy ; — Balneotherapy in psoriasis rehabilitation. In Vivo ; — Utilization indicators of physiotherapy in musculoskeletal and connective tissue disorders for outpatient care.
